Research News for April 27, 2022
advertisement
- Integration of Infant Metabolite, Genetic and Islet Autoimmunity Signatures to Predict Type 1 Diabetes by 6 Years of Age
- The Non-Significant Benefit of BCG Vaccination for the Treatment of Iranian Patients with Type 1 Diabetes up to 48 Weeks: A Controversial Result (Full text HTML, PDF)
- Extracellular Vesicle Therapy for Type 1 Diabetes
- Genetic Modifiers of Thymic Selection and Central Tolerance in Type 1 Diabetes
- The relation between residual β-cell function and autoimmune status in long-term type 1 diabetes patients
- Expression-based Genome-Wide Association Study Links OPN and IL1-RA with Newly Diagnosed Type 1 Diabetes in Children
- Fighting Enteroviral Infections to Prevent Type 1 Diabetes
- The Role of Epigenetic Modifications in Late Complications in Type 1 Diabetes
- Personalized Immunotherapies for Type 1 Diabetes: Who, What, When, and How?